Henry Schein (HSIC) Corporate presentation summary
Event summary combining transcript, slides, and related documents.
Corporate presentation summary
4 Aug, 2026Strategic transformation and market leadership
Evolved from a U.S. mail-order dental distributor to a global leader in dental and medical products, serving over 1 million customers in 34 countries with a $13.2B net sales in FY2025.
Holds #1 global position in dental merchandise and practice management software, and top-three positions in endodontics, implants, and U.S. medical distribution.
BOLD + 1 strategy drives transformation toward high-growth, high-margin businesses, targeting over 50% of non-GAAP operating income from these segments by 2027.
Significant progress in digital transformation, including cloud-based dental software, AI integration, and global eCommerce expansion.
Focused M&A strategy targets bolt-on acquisitions in software, specialty, and services to accelerate growth.
Financial performance and growth
Achieved 11% CAGR in net sales and 12% CAGR in non-GAAP EPS since IPO, with FY2025 net sales of $13.2B and non-GAAP EPS of $4.97.
Operating income reached $972M in 2025, with a 7.37% operating margin; strong cash flow supports ongoing investments and share repurchases.
Value creation initiatives aim to deliver over $200M in operating income improvements by reducing SG&A and enhancing gross margins.
Diversified revenue streams: 84% from distribution and value-added services, 11% from specialty products, and 5% from technology.
Maintains a disciplined capital allocation strategy, balancing organic growth, M&A, and shareholder returns.
Market trends and growth strategies
Benefits from favorable macro trends: aging population, increased healthcare access, digital adoption, and consolidation of practitioners.
Dental market remains stable; medical market sees steady patient growth and share gains.
Long-term strategies include expanding digital workflows, scaling specialty and technology offerings, and deepening customer engagement.
Technology segment leverages recurring revenue, with opportunities to grow average revenue per account and expand globally.
Sustainability initiatives include a net-zero roadmap, supplier engagement, and enhanced ESG reporting.
Latest events from Henry Schein
- Technology, mix shift and productivity underpin growth and value-creation targets.HSIC
Jefferies Global Healthcare Conference - FY2025 sales grew 4%, with a 2027 target to source over half of non-GAAP operating income from high-growth businesses.HSIC
Corporate presentation - Q3 sales rose 4%, adjusted EPS grew 19.1%, and FY2026 EPS guidance increased.HSIC
Q3 2026 - Growth acceleration, operational rigor, and disciplined capital allocation drive strong performance.HSIC
2026 Global Healthcare Conference - Q2 2026 saw strong sales, margin gains, and raised guidance, with robust segment growth.HSIC
Q2 2026 - Lowery’s appointment, share gains and a $200M+ plan underpin growth and BOLD+1 execution.HSIC
44th Annual J.P. Morgan Healthcare Conference - Record Q3 2025 results, raised guidance, and $200M+ value creation initiatives announced.HSIC
Q3 2025 - Q2 2024 sales up 1.1% to $3.14B; net income and EPS declined, and guidance was reduced.HSIC
Q2 2024 - Q4 2024 non-GAAP EPS rose 80% on 5.8% sales growth; 2025 outlook targets steady gains.HSIC
Q4 2024